These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 25476122)

  • 21. Malignant phyllodes tumor of the breast: a systematic review.
    Lissidini G; Mulè A; Santoro A; Papa G; Nicosia L; Cassano E; Ashoor AA; Veronesi P; Pantanowitz L; Hornick JL; Rossi ED
    Pathologica; 2022 Apr; 114(2):111-120. PubMed ID: 35414723
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of phyllodes tumor recurrence according to the histologic grade.
    Kim S; Kim JY; Kim DH; Jung WH; Koo JS
    Breast Cancer Res Treat; 2013 Oct; 141(3):353-63. PubMed ID: 24062207
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Massive infarction of a recurrent phyllodes tumor of the breast: MRI-findings.
    Verslegers I; Tjalma W; Van Goethem M; Colpaert C; Biltjes I; De Schepper AM; Parizel PM
    JBR-BTR; 2004; 87(1):21-2. PubMed ID: 15055329
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Phyllodes tumor of the breast: diagnostic and therapeutic problems].
    Gangi S; Costanzo MP; Prosperini U; Lauria M; Furci M; Strano S; Basile F
    Ann Ital Chir; 1996; 67(2):219-23. PubMed ID: 8929037
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunohistochemical and molecular markers in breast phyllodes tumors.
    Korcheva VB; Levine J; Beadling C; Warrick A; Countryman G; Olson NR; Heinrich MC; Corless CL; Troxell ML
    Appl Immunohistochem Mol Morphol; 2011 Mar; 19(2):119-25. PubMed ID: 21030860
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Breast carcinoma and phyllodes tumour: a case series.
    Sin EI; Wong CY; Yong WS; Ong KW; Madhukumar P; Tan VK; Thike AA; Tan PH; Tan BK
    J Clin Pathol; 2016 Apr; 69(4):364-9. PubMed ID: 26670744
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Cystosarcoma phylloides of the breast. A retrospective analysis of 12 cases].
    Mallebré B; Ebert A; Perez-Cantó A; Hopp H; Opril F; Weitzel H
    Geburtshilfe Frauenheilkd; 1996 Jan; 56(1):35-40. PubMed ID: 8852784
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stromal keratin expression in phyllodes tumours of the breast: a comparison with other spindle cell breast lesions.
    Chia Y; Thike AA; Cheok PY; Yong-Zheng Chong L; Man-Kit Tse G; Tan PH
    J Clin Pathol; 2012 Apr; 65(4):339-47. PubMed ID: 22259180
    [TBL] [Abstract][Full Text] [Related]  

  • 29. p63 expression in breast cancer: a highly sensitive and specific marker of metaplastic carcinoma.
    Koker MM; Kleer CG
    Am J Surg Pathol; 2004 Nov; 28(11):1506-12. PubMed ID: 15489655
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Involvement of α- and β-catenins and E-cadherin in the development of mammary phyllodes tumours.
    Tsang JY; Mendoza P; Lam CC; Yu AM; Putti TC; Karim RZ; Scolyer RA; Lee CS; Tan PH; Tse GM
    Histopathology; 2012 Oct; 61(4):667-74. PubMed ID: 22571452
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunoprofile of metaplastic carcinomas of the breast.
    Rakha EA; Coimbra ND; Hodi Z; Juneinah E; Ellis IO; Lee AH
    Histopathology; 2017 May; 70(6):975-985. PubMed ID: 28029685
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incidentally Discovered Extensive Squamous Metaplasia within Borderline Phyllodes Tumor: Presentation of a Rare Tumor.
    Uğraş N; Tolunay Ş; Öz Atalay F; Gökgöz Ş
    Turk Patoloji Derg; 2016; 32(1):47-50. PubMed ID: 24585350
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD10, actin, and vimentin expression in breast phyllodes tumors correlates with tumor grades of the WHO grading system.
    Tsai WC; Jin JS; Yu JC; Sheu LF
    Int J Surg Pathol; 2006 Apr; 14(2):127-31. PubMed ID: 16703173
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fine needle aspiration cytology of adenomyoepithelioma of the breast: a case indistinguishable from phyllodes tumor in cytologic findings and clinical behavior.
    Lee WY
    Acta Cytol; 2000; 44(3):488-90. PubMed ID: 10834021
    [No Abstract]   [Full Text] [Related]  

  • 35. Immunoreactivity of p53, Ki-67, and c-erbB-2 in phyllodes tumors of the breast in correlation with clinical and morphologic features.
    Shpitz B; Bomstein Y; Sternberg A; Klein E; Tiomkin V; Kaufman A; Groisman G; Bernheim J
    J Surg Oncol; 2002 Feb; 79(2):86-92. PubMed ID: 11815995
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Malignant phyllodes tumor of the breast with predominant chondrosarcomatous differentiation.
    Vera-Sempere F; García-Martínez A
    Pathol Res Pract; 2003; 199(12):841-5. PubMed ID: 14989497
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phyllodes tumors of the breast diagnostic and therapeutic dilemmas.
    Fajdić J; Gotovac N; Hrgović Z; Kristek J; Horvat V; Kaufmann M
    Onkologie; 2007 Mar; 30(3):113-8. PubMed ID: 17341897
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of p53 protein and Ki-67 antigen in phyllodes tumor of the breast.
    Chan YJ; Chen BF; Chang CL; Yang TL; Fan CC
    J Chin Med Assoc; 2004 Jan; 67(1):3-8. PubMed ID: 15077883
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic Molecular and Biological Characteristics of Phyllodes Tumors of the Breast.
    Vorotnikov IK; Vysotskaya IV; Denchik DA; Letyagin VP; Davydov MM; Kirsanov VY; Kim EA; Buseva VS
    Bull Exp Biol Med; 2020 Oct; 169(6):806-810. PubMed ID: 33098518
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of stromal CD10 expression in benign, borderline, and malignant phyllodes tumors among Egyptian female patients.
    Ibrahim WS
    Indian J Pathol Microbiol; 2011; 54(4):741-4. PubMed ID: 22234101
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.